Is a fatty pancreas a banal lesion?
So far, a fatty pancreas has been related to obesity and the ageing processes in the body. The current list of pathogenetic factors of the condition is clearly extended with genetically conditioned diseases (cystic fibrosis, Shwachman-Diamond syndrome and Johanson-Blizzard syndrome), pancreatitis, especially hereditary and obstructive, metabolic and hormonal disorders (hypertriglyceridemia, hypercholesterolemia, hyperinsulinemia and hypercortisolemia), alcohol overuse, taking some medicines (especially adrenal cortex hormones), disease of the liver and visceral adiposis. As regards lipomatosis of that organ resulting mainly from dyslipidemia and hyperglycemia, the term "nonalcoholic fatty pancreas disease" was introduced. Experimental studies on animals and histological preparations of the pancreatic fragments show that the lipotoxicity of the collected adipocytes collected ion the organ release a cascade of proinflammatory phenomena, and even induces the processes of carcinogenesis. Pancreas adiposis is best defined in Computed Tomography and Magnetic Resonance Imaging. However, a series of works proved the usefulness in the diagnostics of that pathology of transabdominal and endoscopic ultrasonography. In that method, the degree of adiposis was based on the comparison of echogenicity of the pancreas and the liver, renal parenchyma, spleen and/or retroperitoneal adipose. Recently, the evaluation was expanded by the evaluation of the degree of pancreatic adipose with the pancreas-to-liver index, utilizing to that end a special computer program. According to our experience, the simplest solution is the method utilized by us. On one crosssection of the body of the pancreas, its echogenicity is assessed in comparison to retroperitoneal adipose and the visibility of the splenic vein, pancreatic duct and the major retroperitoneal vessels. Depending on the visualization of these structures, it is possible to determine the degree of pancreas adiposis. Such a study applies to 250 people, in whom the adiposis was detected in 16.5%, which is close to other cohort US examinations results.
Self-Training Ultrasonography Circle at the Genetics and Pathomorphology Center in Szczecin, Szczecin, Poland.
Andrzej
A
Smereczyński
Self-Training Ultrasonography Circle at the Genetics and Pathomorphology Center in Szczecin, Szczecin, Poland.
Katarzyna
K
Kołaczyk
adiposis; adiposis classification; nonalcoholic fatty pancreas disease; pancreas; ultrasonography
Radiology. 1991 Apr;179(1):183-6
2006275
Pancreas. 2010 Nov;39(8):1185-90
20871475
Pancreas. 2014 Oct;43(7):1032-41
24991971
World J Gastroenterol. 2009 Apr 21;15(15):1869-75
19370785
Pediatr Radiol. 1985;15(5):348-9
3897999
Am J Gastroenterol. 2014 Apr;109(4):589-97
24492753
Gastrointest Endosc. 2011 May;73(5):987-93
21521567
J Comput Assist Tomogr. 1993 May-Jun;17 (3):474-6
8491914
Sci Transl Med. 2011 Nov 2;3(107):107ra110
22049070
PLoS One. 2013 May 03;8(5):e62561
23671610
JOP. 2014 Jul 28;15(4):388-90
25076350
Clin Cancer Res. 2015 Aug 1;21(15):3522-8
25700304
Pancreas. 2009 Aug;38(6):672-5
19506531
J Clin Ultrasound. 2015 Feb;43(2):98-108
25044163
Cardiovasc Diabetol. 2013 May 20;12 :77
23688357
Eur J Pediatr. 2011 Feb;170(2):179-83
20556422
World J Diabetes. 2014 Aug 15;5(4):415-9
25126389
J Ultrasound Med. 1984 Jan;3(1):9-14
6694259
Pancreatology. 2014 Sep-Oct;14(5):403-8
25278311
Acta Pathol Microbiol Scand A. 1978 Sep;86A(5):367-73
716899
Eur J Intern Med. 2015 Jan;26(1):37-41
25491010
Radiology. 1995 Feb;194(2):453-8
7824726
Gerontology. 2000 Mar-Apr;46(2):93-6
10671806
J Am Heart Assoc. 2014 Feb 26;3(1):e000297
24572250
Am J Clin Nutr. 2013 Oct;98(4):1057-65
23985810
J Endocrinol Invest. 2012 Sep;35(8):748-53
21979274